| Anestesiology and Intensive Care: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Barna Babik |
pneumonia |
|
| Internal Medicine: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Tamas Molnar |
Crohn's disease, colitis ulcerosa |
| Zoltan Ruzsa |
myocardial infarction, coronary disease, coronary syndrome |
| Attila Farkas |
cardiac failure, familial hypercholesterolemia |
| Robert Takacs |
renal disease, cardiovascular diseases, obesity, type 2 diabetes |
| Zita Borbenyi |
acute myeloid leukaemia, Hodgkin's lymphoma, amyloidosis, Mantle cell lymphoma, myelodysplastic syndrome, myelofibrosis |
| Laszlo Czako |
short bowel syndrome, IgG4-related disease
|
| Robert Sepp |
hypertrophic cardiomyopathy, cardiomyopathies |
| Edit Hajdu |
hepatitis B, COVID-19, Clostridium difficile |
| Szabolcs Modok, MD, PhD |
mantle cell lymphoma, multiple myeloma, follicular lymphoma, diffuse large B-cell lymphoma, myelofibrosis, myelodysplasia |
| Szabolcs Nyiraty |
hypertension |
| Zoltan Szepes |
colitis ulcerosa, colitis |
| Tamas Varkonyi |
type 2 diabetes, neuropathy |
| Laszlo Zsolt Bito |
nephropathy |
| Imola Fejes |
hypertension |
| Laszlo Nagy |
myocardial infarction, stroke |
| Zoltan Ondrik |
renal diseases |
| Zsuzsanna Valkusz |
diabetes, gastroenteropancreatic neuroendocrine tumour |
| Mate Vamos |
ischaemic stroke, cardiovascular diseases, atrial fibrillation |
|
| Dermatology and Allergology: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Lajos Kemeny |
atopic dermatitis (adult, pediatric), psoriasis, alopecia areata, chronic spontaneous urticaria, prurigo nodularis, hidradenitis suppurativa |
| Rolland Gyulai |
vitiligo, psoriasis, septic arthritis, hidradenitis suppurativa, alopecia, atopic dermatitis, squamous cell carcinoma |
| Zsuzsanna Bata |
pemphigus, atopic dermatitis, dermatomyositis, urticaria |
| Eszter Baltas |
melanoma, psoriasis |
| Döniz Degovics |
hidradenitis suppurativa |
| Aniko Maraz |
solid tumours |
|
| Family Medicine: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Albert Varga |
hypertension, cardiac failure, increased lipoprotein (a) levels, cardiovasular events, mechanical dyssynchrony, type 1 diabetes, pulmonary arterial hypertension, atrial fibrillation, renal diseases |
|
| Pediatrics: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Csaba Bereczki |
colitis ulcerosa, iron-deficiency anemia, proteinuria, atypical hemolytic uremic syndrome (aHUS), Crohn’s disease, adeno-associated viruses |
| Krisztina Kapornai |
Tourette's syndrome, autism spectrum disorder, schizophrenia |
|
| Neurology: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Peter Klivenyi |
stroke, Parkinson’s disease, transthyretin amiloid polineuropathy, cerebral amyloid angiopathy, multiple sclerosis, myesthenia gravis
|
| Laszlo Vecsei |
Pompe disease, relapsing-remitting multiple sclerosis, neuromyelitis optica spectrum disorder
|
|
| Oncology: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Aliz Nikolenyi |
breast cancers |
| Katalin Hideghety |
squamous cell carcinoma in the head and neck region |
| Judit Olah |
prostate cancer, melanoma, squamous cell carcinoma, bladder cancer, hepatucellular carcinoma, Clear cell renal cell carcinoma (ccRCC), metastatic melanoma, EOC |
|
| Rheumatology: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Attila Balog |
arthritis psoriatica, Sjögren’s syndrome, inflammatory spinal disease, giant cell arteritis (GCA)
|
| Laszlo Kovacs |
systemic sclerosis, systemic lupus, Sjögren’s syndrome
|
| Daniella Ladoczky-Hullo |
rheumatoid arthritis |
|
| Ophtalmology: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Edit Toth-Molnar |
macular degeneration, diabetic macular edema, neurotrophic keratitis |
| Aron Szabo |
glaucoma |
|
| Obstetrics and Gynaecology: |
| Principal investigator’s full name |
Indications of clinical trials (2022-2024) |
| Attila Keresztúri |
contraception, endometriosis |
| Gabor Nemeth |
endometriosis |
